Director, Clinical and Translational Research
Caris Life Sciences
Andrew Elliott earned a PhD in Molecular and Cellular Biochemistry at Indiana University, where he studied molecular mechanisms of intracellular organiation and morphogenesis. After postdoctoral training at the Huntsman Cancer Institution that focused on oncogenic mechanisms of cell migration and metastasis in lung cancer, Andrew joined Caris Life Sciences as a Research Scientist on the Clinical and Translational Research team. He is currently the Director of Clinical and Translational Research at Caris Life Sciences and continues to pursue research studies across the solid tumor landscape, with a special interest in sarcoma and other rare cancers.
